300404.SZ Stock Analysis
30
Avoid
Based on Eyestock quantitative analysis, 300404.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Boji Medical Technology Co., Ltd. is a contract research organization(CRO) that offers outsourcing drugs research and development services, including new drugs evaluation and clinical trials, preclinical studies and researches, medical devices registration, data management, biostatistics and other consultation services. The company is headquartered in Guangzhou, Guangdong and currently employs 989 full-time employees. The company went IPO on 2015-04-24. The firm mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The firm's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The firm mainly conducts its businesses in the domestic market.